| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,566 |
29,610 |
$3.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,171 |
25,674 |
$1.76M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,685 |
5,221 |
$701K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15,336 |
14,107 |
$629K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,982 |
6,375 |
$564K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,764 |
9,121 |
$352K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,522 |
12,446 |
$344K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,293 |
5,762 |
$297K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,721 |
5,233 |
$190K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
688 |
507 |
$173K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,724 |
5,194 |
$167K |
| 80053 |
Comprehensive metabolic panel |
19,026 |
16,703 |
$140K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,625 |
18,003 |
$113K |
| 71045 |
Radiologic examination, chest; single view |
4,711 |
4,298 |
$112K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,793 |
3,880 |
$94K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,997 |
2,740 |
$92K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,516 |
1,349 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
26,307 |
22,962 |
$59K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,196 |
1,007 |
$56K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,500 |
1,988 |
$51K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
139 |
131 |
$50K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
279 |
116 |
$47K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,536 |
2,681 |
$40K |
| 99215 |
Prolong outpt/office vis |
715 |
660 |
$37K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
265 |
236 |
$37K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,233 |
1,046 |
$35K |
| 80050 |
General health panel |
761 |
711 |
$31K |
| 81025 |
|
4,451 |
4,059 |
$31K |
| 80061 |
Lipid panel |
2,709 |
2,433 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,098 |
1,821 |
$28K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,082 |
2,760 |
$24K |
| 70450 |
Computed tomography, head or brain; without contrast material |
142 |
126 |
$22K |
| 81000 |
|
6,975 |
6,247 |
$21K |
| 84439 |
|
2,673 |
2,389 |
$19K |
| 84484 |
|
2,675 |
2,234 |
$19K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
141 |
117 |
$19K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
358 |
328 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
647 |
510 |
$16K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
854 |
713 |
$16K |
| 83880 |
|
686 |
622 |
$15K |
| 83690 |
|
2,775 |
2,527 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,150 |
5,406 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,977 |
1,714 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
148 |
141 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
602 |
502 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
25 |
24 |
$10K |
| 87634 |
|
150 |
142 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
187 |
165 |
$8K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
15 |
15 |
$8K |
| 83525 |
|
852 |
754 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
164 |
125 |
$8K |
| J3490 |
Unclassified drugs |
1,350 |
1,004 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
208 |
179 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
267 |
198 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
248 |
198 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
254 |
238 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
280 |
210 |
$7K |
| 87631 |
|
51 |
44 |
$7K |
| 73562 |
|
105 |
83 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
277 |
242 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
147 |
128 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
18 |
15 |
$5K |
| 81001 |
|
2,316 |
1,756 |
$5K |
| 74018 |
|
102 |
94 |
$5K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
46 |
39 |
$5K |
| 81003 |
|
2,481 |
2,277 |
$4K |
| 83735 |
|
817 |
757 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
133 |
30 |
$3K |
| 86376 |
|
271 |
226 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,292 |
2,880 |
$3K |
| 0001A |
|
106 |
104 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
123 |
69 |
$3K |
| 81514 |
|
15 |
12 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
113 |
106 |
$3K |
| 59025 |
Fetal non-stress test |
62 |
40 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
133 |
124 |
$2K |
| 86803 |
|
193 |
159 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
104 |
92 |
$2K |
| 90677 |
|
48 |
41 |
$2K |
| 20610 |
|
89 |
57 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
130 |
85 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
49 |
49 |
$2K |
| 85730 |
|
570 |
510 |
$2K |
| 83550 |
|
226 |
199 |
$2K |
| 86592 |
|
476 |
416 |
$2K |
| 84481 |
|
149 |
130 |
$2K |
| 87581 |
|
51 |
46 |
$2K |
| 87486 |
|
51 |
46 |
$2K |
| 73630 |
|
26 |
25 |
$1K |
| 85610 |
|
581 |
542 |
$1K |
| 85027 |
|
344 |
309 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
34 |
26 |
$1K |
| 86703 |
|
114 |
107 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
262 |
230 |
$1K |
| 83540 |
|
240 |
211 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,806 |
1,590 |
$1K |
| 83605 |
|
155 |
138 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
110 |
106 |
$1K |
| 84436 |
|
200 |
160 |
$1K |
| 82962 |
|
461 |
386 |
$1K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
27 |
25 |
$1K |
| 86787 |
|
104 |
77 |
$926.90 |
| 0004A |
|
23 |
23 |
$899.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
454 |
357 |
$795.73 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
269 |
250 |
$731.13 |
| 84480 |
|
89 |
85 |
$695.86 |
| 82105 |
|
46 |
40 |
$618.40 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
382 |
326 |
$585.93 |
| 0002A |
|
13 |
13 |
$525.88 |
| 73130 |
|
12 |
12 |
$511.66 |
| 90715 |
|
76 |
64 |
$460.05 |
| 80074 |
|
12 |
12 |
$447.96 |
| 87081 |
|
48 |
38 |
$399.54 |
| 76801 |
|
16 |
13 |
$382.87 |
| 82728 |
|
28 |
27 |
$370.08 |
| 84702 |
|
25 |
24 |
$347.58 |
| 90686 |
|
97 |
96 |
$337.98 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
75 |
64 |
$286.90 |
| 86850 |
|
55 |
50 |
$232.88 |
| 86696 |
|
12 |
12 |
$221.84 |
| 87077 |
|
32 |
28 |
$211.84 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
16 |
13 |
$204.55 |
| 87186 |
|
34 |
28 |
$200.61 |
| 82043 |
|
36 |
34 |
$198.56 |
| 94761 |
|
14 |
12 |
$193.37 |
| 82570 |
|
36 |
35 |
$183.22 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
28 |
26 |
$172.18 |
| 87088 |
|
28 |
27 |
$170.62 |
| 86695 |
|
12 |
12 |
$151.24 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
44 |
31 |
$126.10 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
19 |
$110.92 |
| 80069 |
|
12 |
12 |
$96.52 |
| 86900 |
|
42 |
38 |
$87.19 |
| 86901 |
|
42 |
38 |
$87.19 |
| 81002 |
|
28 |
24 |
$84.19 |
| J7510 |
Prednisolone oral, per 5 mg |
41 |
36 |
$77.76 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
79 |
70 |
$72.67 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
39 |
37 |
$70.39 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
63 |
51 |
$57.62 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
228 |
134 |
$54.51 |
| 82950 |
|
13 |
13 |
$52.64 |
| 82947 |
|
30 |
13 |
$40.51 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
14 |
14 |
$40.44 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
45 |
25 |
$37.43 |
| J2704 |
Injection, propofol, 10 mg |
139 |
86 |
$18.13 |
| J2060 |
Injection, lorazepam, 2 mg |
17 |
12 |
$13.92 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
16 |
12 |
$8.02 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
116 |
106 |
$1.43 |
| 91300 |
|
234 |
216 |
$0.00 |
| 99001 |
|
70 |
28 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
23 |
15 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
17 |
15 |
$0.00 |
| A9270 |
Non-covered item or service |
34 |
26 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
59 |
48 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15 |
13 |
$0.00 |
| 90656 |
|
28 |
26 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
17 |
12 |
$0.00 |